Independent validation of a model predicting the need for packed red blood cell transfusion at liver transplantation

Transplantation

Volumn 88, Issue 3, 2009, Pages 386-391

  Massicotte, Luc ^a   Capitanio, Umberto ^b   Beaulieu, Danielle ^a   Roy, Jean Denis ^a   Roy, André ^a   Karakiewicz, Pierre I ^b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Liver transplantation; Prediction; Transfusion

Indexed keywords

HEMOGLOBIN;

ADULT; ARTICLE; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; NOMOGRAM; PHLEBOTOMY; PLASMA TRANSFUSION; PRIORITY JOURNAL;

ADULT; AREA UNDER CURVE; BLOOD COMPONENT TRANSFUSION; BLOOD LOSS, SURGICAL; ERYTHROCYTE TRANSFUSION; HEMOGLOBINS; HUMANS; LIVER TRANSPLANTATION; LOGISTIC MODELS; MIDDLE AGED; MODELS, BIOLOGICAL; NOMOGRAMS; ODDS RATIO; PHLEBOTOMY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 69449107963     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181aed477     Document Type: Article

References (27)

1. Butler P, Israel L, Nusbacher J, et al. Blood transfusion in liver transplantation. Transfusion 1985; 25: 120.
2. Cacciarelli TV, Keeffe EB, Moore DH, et al. Effect of intraoperative blood transfusion on patient outcome in hepatic transplantation. Arch Surg 1999; 134: 25.
3. Ramos E, Dalmau A, Sabaté A, et al. Intraoperative red blood cell transfusion in liver transplantation: Influence on patient outcome, prediction of requirements, and measures to reduce them. Liver Transpl 2003; 9: 1320. (Pubitemid 37540380)
4. Massicotte L, Sassine M-P, Lenis S, et al. Survival rate changes with transfusion of blood products during liver transplantation. Can J Anaesth 2005; 52: 148. (Pubitemid 40467971)
5. Massicotte L, Beaulieu D, Thibeault L, et al. Coagulation defects do not predict blood product requirements during liver transplantation. Transplantation 2008; 85: 956. (Pubitemid 351543157)
6. Hendriks HG, van der Merr J, de Wolf JT, et al. Intraoperative blood transfusion requirement is the main determinant of early surgical reintervention after orthotopic liver transplantation. Transpl Int 2005; 17: 673.
7. Boyd SD, Stenard F, Lee DKK, et al. Alloimmunization to red blood cell antigens affects clinical outcomes in liver transplant patients. Liver Transpl 2007; 13: 1654.
8. Steib A, Freys G, Lehmann C, et al. Intraoperative blood losses and transfusion requirements during adult liver transplantation remain difficult to predict. Can J Anaesth 2001; 48: 1075. (Pubitemid 34223642)
9. Massicotte L, Sassine M-P, Lenis S, et al. Transfusion predictors in liver transplant. Anesth Analg 2004; 98: 1245.
10. Frasco PE, Poterack KA, Hentz JG, et al. A comparison of transfusion requirements between living donation and cadaveric donation liver transplantation: Relationship to model of end-stage liver disease score and baseline coagulation status. Anesth Analg 2005; 101: 30.
11. De Boer MT, Molenar IQ, Hendriks HG, et al. Minimizing blood loss in liver transplantation: Progress through research and evolution of techniques. Dig Surg 2005; 22: 265.
12. Lodge JP, Jonas S, Jones RM, et al. Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation. Liver Transpl 2005; 11: 973. (Pubitemid 41122456)
13. Planinsic RM, van der Meer J, Tests G, et al. Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease. Liver Transpl 2005; 11: 895. (Pubitemid 41122446)
14. Ozier Y, Pessione F, Samain E, et al; French Study Group on Blood Transfusion in Liver Transplantation. Institutional variability in transfusion practice for liver transplantation. Anesth Analg 2003; 97: 671.
15. Glantz SA, Slinker BK. Primer of applied regression and analyses of variance. New York, McGraw-Hill, Inc. 1990, pp 514.
16. Massicotte L, Lenis S, Thibeault L, et al. Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantation. Liver Transpl 2006; 12: 117.
17. Royston D, Bidstrup BP, Taylor KM, et al. Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet 1987; 2: 1289. (Pubitemid 17156632)
18. Capitanio U, Jeldres C, Shariat SF, et al. Clinicians are most familiar with nomograms and rate their clinical usefulness highest, look-up tables are second best. Eur Urol 2008; 54: 958.
19. Matinlauri IH, Nurminen MM, Hockerstedt KA, et al. Risk factors predicting survival of liver transplantation. Transplant Proc 2005; 37: 155.
20. Lee DS, Gil WH, Lee HH, et al. Factors affecting graft survival after living donor liver transplantation. Transplant Proc 2004; 36: 2255.
21. Massicotte L, Thibeault, Beaulieu D. Low CVP during liver transplantation. J Cardiothorac Vasc Anesth 2008; 22: 315.
22. Brown RS, Kumar KS, Russo MW, et al. Model for end-stage liver disease and Child-Turcotte Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in united network for organ sharing status 2A patients. Liver Transpl 2002; 8: 278.
23. Shan WLP, Barkun J, Metrakos P, et al. Blood product use during orthotopic liver transplantation. Can J Anaesth 2004; 51: 1045. (Pubitemid 40104123)
24. Schroeder RA, Collins BH, Tuttle-Newhall E, et al. Intraoperative fluid management during orthotopic liver transplantation. J Cardiothorac Vasc Anesth 2004; 18: 438.
25. Costa MG, Chiarandini P, Della Rocca G. Hemodynamics during liver transplantation. Transplant Proc 2007; 39: 1871.
26. Pugliese F, Ruberto F, Summonti D, et al. Activated recombinant factor VII in orthotopic liver transplantation. Transplant Proc 2007; 39: 1883. (Pubitemid 47198825)
27. Levy JH, Tanaka KA, Dietrich W. Perioperative hemostatic management of patients treated with vitamin k antagonists. Anesthesiology 2008; 109: 918.